Plexus - PLXS Stock Forecast, Price & News

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Plexus in the last year. There are currently 1 sell rating and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" PLXS shares.
View PLXS analyst ratings or view top-rated stocks.

5 Wall Street research analysts have issued 12 month target prices for Plexus' shares. Their PLXS share price forecasts range from $86.00 to $116.00. On average, they predict the company's share price to reach $107.00 in the next twelve months. This suggests a possible upside of 7.2% from the stock's current price.
View analysts price targets for PLXS or view top-rated stocks among Wall Street analysts.

Plexus' stock was trading at $102.93 on January 1st, 2023. Since then, PLXS shares have decreased by 3.0% and is now trading at $99.83.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, April 26th 2023.
View our PLXS earnings forecast.

Plexus Corp. (NASDAQ:PLXS) posted its earnings results on Wednesday, January, 25th. The technology company reported $1.49 EPS for the quarter, topping analysts' consensus estimates of $1.47 by $0.02. The technology company earned $1.09 billion during the quarter, compared to analyst estimates of $1.11 billion. Plexus had a trailing twelve-month return on equity of 14.45% and a net margin of 3.84%. The firm's revenue was up 33.8% compared to the same quarter last year. During the same period last year, the firm posted $0.88 earnings per share.

Plexus issued an update on its second quarter 2023 earnings guidance on Wednesday, January, 25th. The company provided EPS guidance of $1.06-$1.24 for the period, compared to the consensus EPS estimate of $1.40. The company issued revenue guidance of $1.02 billion-$1.07 billion, compared to the consensus revenue estimate of $1.10 billion.

80 employees have rated Plexus Chief Executive Officer Todd Kelsey on Glassdoor.com. Todd Kelsey has an approval rating of 77% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Plexus investors own include Bristol-Myers Squibb (BMY), Pfizer (PFE), Walgreens Boots Alliance (WBA), Berry Global Group (BERY), Cisco Systems (CSCO), Intel (INTC), QUALCOMM (QCOM), Teledyne FLIR (FLIR), First Solar (FSLR) and Gilead Sciences (GILD).

Plexus trades on the NASDAQ under the ticker symbol "PLXS."

Plexus' stock is owned by many different institutional and retail investors. Top institutional shareholders include Fisher Asset Management LLC (0.99%), New York State Common Retirement Fund (0.81%), Scout Investments Inc. (0.31%), New York State Teachers Retirement System (0.20%), Smith Graham & Co. Investment Advisors LP (0.16%) and Envestnet Asset Management Inc. (0.12%). Insiders that own company stock include Angelo Michael Ninivaggi Jr, Dean A Foate, J Joel Quadracci, Michael V Schrock, Patrick John Jermain, Ronnie Darroch, Scott Theune, Stephen P Cortinovis, Steven J Frisch, Todd P Kelsey and Yong Jin Lim.
View institutional ownership trends.

Shares of PLXS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of PLXS stock can currently be purchased for approximately $99.83.

Plexus (NASDAQ:PLXS) has a market capitalization of $2.76 billion and generates $3.81 billion in revenue each year. The technology company earns $138.24 million in net income (profit) each year or $5.55 on an earnings per share basis.

The company employs 25,000 workers across the globe.

Plexus' mailing address is One Plexus Way, Neenah WI, 54957. The official website for the company is www.plexus.com. The technology company can be reached via phone at (920) 969-6000, via email at heather.beresford@plexus.com, or via fax at 920-751-5395.